Recent Presentations

March 7-12, 2010: Antibody Biology and Engineering Gordon Research Conference
Jon Weidanz, Ph.D., Chief Scientist of Receptor Logic will be presenting at the Gordon Research Conference on Antibody Biology and Engineering on Thursday,
March 11, 2010, on “Therapeutic potential of T-cell receptor mimic monoclonal antibodies.”
April 14-16, 2010: Human Antibodies & Hybridomas International Conference
Jon Weidanz, Ph.D., Chief Scientist of Receptor Logic will be presenting at the Human Antibodies & Hybridomas International Conference on Thursday, April 15th, 2010, on “Anti-tumor properties of T-cell receptor mimic monoclonal antibodies.”

 

News About Receptor Logic

March 10, 2010: Receptor Logic Chief Scientist to Present at Antibody Biology and Engineering Gordon Research Conference  (pdf)
January 26, 2010: Texas Governor Rick Perry Praises Receptor Logic at Visit to the Abilene Life Sciences Accelerator(ALSA)  (pdf)
September 02, 2009: Receptor Logic, Inc. Awarded National Cancer Institute Grant
May 13, 2009: Receptor Logic, Inc. Launches New Website (pdf)
May 11, 2009: Texas Pavilion Booth #4633 at the BIO International Convention May 18-21
July 18, 2008: Receptor Logic TETF Investment Briefing (pdf)
July 18, 2008: $2M grant seen as good omen for local biotech company (Abilene Reporter News)
July 17, 2008: Abilene urged to support biotechnology center (Abilene Reporter News)
February 27, 2008: Receptor Logic Teams With Sanofi Pasteur To Develop T-Cell Receptor Mimics (TCRm™) for Vaccine Research (pdf)
February 11, 2008: Receptor Logic Quarterly Update-Winter 2008 (pdf)
June 5, 2007: Receptor Logic Chief Scientist to Speak At FOCIS Immunology Conference
September 15, 2006: Antibody Targeting to Class I MHC-peptide Epitope Promotes Tumor Cell Death
September 30, 2004: Receptor Logic receives $2 million advanced technology program award
March 26, 2004: Emergent Technologies, Inc. licenses drug discovery technology from Texas Tech University